Sernova Biotherapeutics (SVA.TO) Q1 2026 Earnings

Mar 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.02
-0.02
-0.01
-0.01

Details

Expected EPS
-0.010047531339999999
Actual EPS
-0.010047531339999999
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Sernova Biotherapeutics⁩ (⁦SVA.TO⁩) has reported earnings of ⁦-0.010047531339999999⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts